cDNA-derived amino acid sequence of L-histidine decarboxylase from mouse mastocytoma P-815 cells  by Yamamoto, Jun et al.
Volume 276, number 1,2, 214-218 FEBS 09218 December 1990 
cDNA-derived amino acid sequence of L-histidine decarboxylase from 
mouse mastocytoma P-8 15 cells 
Jun Yamamoto, Kimio Yatsunami, Eiji Ohmori, Yukihiko Sugimoto, Tetsuya Fukui, Toyoko Katayama’ 
and Atsushi Ichikawa 
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606 and 
‘Laboratory of Genetics, Institute for Biomedical Research, Suntory Ltd, Mishima-gun, Osaka 618, Japan 
Received 13 October 1990 
The primary structure of L-hi&dine decarboxylase (HDC: L-histidine carboxy-lyase, EC 4.1.1.22) from mouse mastocytoma P-81 5 cells has been 
determined by parallel analysis of the amino acid sequence of the protein and the nucleotide sequence of the corresponding cDNA. HDC contains 
662 amino acid residues with a molecular mass of 74 017, which is larger by about 21000 Da than that of the previously purified HDC subunit 
(53 kDa), suggesting that HDC might be posttranslationally processed. The HDC cDNA hybridized to a 2.7 kilobase mRNA of mastocytoma 
cells. Homology was found between the sequences of mouse mastocytoma HDC and fetal rat liver HDC. 
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1. INTRODUCTION 
In the central nervous system and various peripheral 
organs, histamine acts as a neurotransmitter or a 
modulator of inflammatory reactions, gastric acid 
secretion and other processes [ 11. L-Histidine decarbox- 
ylase (HDC; L-histidine carboxy-lyase, EC 4.1.1.22) 
catalyzes the formation of histamine from its precursor, 
histidine, in a single step. Thus, clarification of the con- 
trol mechanism for HDC activity and of its synthesis is 
necessary not only from biochemical but also clinical 
aspects. 
We have recently succeeded in purifying and charac- 
terizing HDC from mouse mastocytoma P-8 15 cells [6], 
and have begun to isolate cDNA clones for the HDC 
subunit in the cells in order to determine its primary 
structure and the genetic relationship between HDC 
and other decarboxylases, and also to clarify the 
regulatory mechanism for histamine synthesis. 
2. MATERIALS AND METHODS 
HDC was purified from mastocytoma P-815 cells as previously 
Most recently, the cDNA-derived amino acid se- 
quence of HDC in fetal rat liver with a molecular mass 
of 73 450 (655 amino acid residues) was reported, which 
was determined without purification of the enzyme dur- 
ing studies on the genes for androgen-binding proteins 
[2]. However, no information is available as to which 
cells the HDC originated from. 
reported [6], and was digested with Achromobucter protease RAP-I) 
at 37°C for 2 h in the presence of dithiothreitol. The resultant pep- 
tides were separated on a reverse-phase HPLC column (YMC A-302) 
and the peptide fragments were analyzed using a gas-phase sequencer 
model 477A equipped with an on-line PTH analyzer model 120A (Ap- 
plied Biosystems). 
Mouse mastocytoma cells are the proper cell type for 
elucidating the mechanism underlying histamine forma- 
tion in mast cells, because they synthesize HDC in 
response to various stimuli. For instance, we have 
previously shown that glucocorticoids stimulate hista- 
mine synthesis by inducing HDC in mouse neoplastic 
mast cells (mastocytoma P-815 cells) [3], and in rat 
stomach [4]. In addition, preliminary experiments have 
shown that HDC is induced through protein kinases A 
and/or C [5]. 
The sense and antisense primers corresponding to the peptide se- 
quences, Met-Leu-Gly-Leu-Pro-Glu-Tyr-Phe (residues l-8 of peptide 
12) and His-Gly-Thr-Glu-Met-Ala-Lys (residues 8-14 of peptide l), 
respectively, were synthesized. They were 5’-ATGCTGGGGCT- 
CCCTGARTAYTT-3 ’ and 5 ’ -TTGGCCATCTCTGTRCCRTG-3 ’ , 
respectively (where R is A or G; and Y is C or T). 
Single-stranded cDNA was synthesized from 5 pug of poly(A)+RNA 
of P-815 cells and used as a template for the synthesis of a cDNA pro- 
be by means of the PCR protocol. The reaction conditions were as 
follows: PCR buffer (50 mM KCl, 10 mM Tris-HCI (pH 8.3) and 
0.01% gelatin); sense and antisense primers (1 CM each); 2.6 cg of 
template DNA; 1.5 mM MgClz; dATP, dCTP, dGTP and dTTP (200 
pM each); and 2.5 units of Taq DNA polymerase were mixed, the 
total reaction volume being 100 ~1. The reaction was allowed to pro- 
ceed for 30 cycles of denaturation (40 set at 94”C), annealing (1 min 
at 46’C) and polymerization (2 min at 72”(Z), followed by a single 10 
min extension at 72°C using an automated heating/cooling block 
(Zymoreactor, Atto Corp.) 
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Fig. 1. Synthesis of a cDNA probe for HDC from P-815 cells. (A) Separation of AP-I-digests by reverse-phase HPLC. (B) Partial amino acid se- 
quences of peptides (1-12). Boxes indicate differences in amino acid residues between HDC of P-815 cells and that of rat liver. The sequences used 
for the synthesis of primers are underlined. (-); not detected. (C) Visualization of the cDNA probe separated on a 1.0% agarose gel. 
Double-stranded cDNAs were prepared from total poly(A)+RNA 
according to Gubler and Hoffman [8], and size-fractionated cDNAs 
(> 500 bp) were inserted into the unique EcoRI site of hgtll [9]. 
Recombinant phages were screened using the ‘*P-labeled HDC cDNA 
probe. 
3. RESULTS 
The purified HDC was digested with AP-I, and the 
peptidic fragments thus obtained were separated 
(Fig. 1A). Fig. 1B shows the twelve partial amino acid 
sequences that were determined by the automated Ed- 
man degradation method. Of these sequences, the two 
for peptides 1 and 12 were selected to generate primers 
for the preparation of a cDNA probe as described in 
section 2. Fig. 1C shows the visualized fragment of the 
amplified cDNA product with a size of about 780 bp, 
which is in good agreement with the size of 782 bp ex- 
pected from the sequence of rat HDC [2]. 
During the primary screening of the cDNA library, 
20 phage plaques out of 80000 recombinants gave 
positive signals, 7 of which were chosen and purified. 
All of the latter were ultimately proved by nucleotide se- 
quence analysis to contain coding sequences for the par- 
tial amino acid sequences determined for HDC 
(Fig. 1A) in the same reading frame. hHDC1 (2.4 kb) 
contained the complete coding sequence for HDC in- 
cluding the 3 ‘-terminal poly(A) tract. 
Fig. 2A shows the restriction maps and the results of 
sequence analysis of the cDNA clones. Fig. 2B shows 
the 2371-nucleotide sequence of the cDNA encoding 
HDC in P-815 cells. Thus, there is a stretch of 74 
nucleotides in the 5 ’ non-coding region, and the coding 
sequence for HDC begins at an initiator codon 
(nucleotides l-3) and ends with a TGA terminator 
codon (nucleotides 1987-1989). There is an additional 
sequence of 311 nucleotides downstream from the ter- 
minator codon. A presumed recognition site for 
polyadenylylation, A-A-T-A-A-A, was found at posi- 
tions 2263-2268 in the 3 ’ non-coding region, 15 bp 
upstream of the poly(A) tract. When the HDC cDNA 
was subcloned into the eukaryotic expression vector 
pcDNA-I, a modified pCMV plasmid, and transfected 
into COS-1 cells, the enzymatic activity of HDC was 
detected (data not shown). 
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Total RNA prepared from P-8 15 cells was hybridized 
to “P-labeled HDC cDNA at 65°C for 15 h. As shown 
in Fig. 3, a single band corresponding to 2.7 kilobases 
was observed. 
4. DISCUSSION 
The cDNA-derived amino acid sequence of HDC 
from mouse mastoc~oma P-815 cells comprises 662 
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Fig. 2. Sequence analysis of HDC cDNA clones. (A) Restriction maps of 5 cDNA clones. The amino acid coding region is shown as a bold line. 
(B) Sequences of cDNA and amino acids of HDC. The partial amino acid sequences determined by amino acid sequence analysis (Fig. IB) are 
underlined. A consensus poly(A) signal is boxed. (. . .) and (-) indicate potential sites of N-glycosylation and of phosphoryiation by CAMP- 
dependent protein kinase, respectively. The nucieotide sequence was determined by the dideox~ucl~tide chain-termination method of Sanger et 
al. [lo]. 
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HDC from P-815 cells may be posttranslationally pro- 
cessed. That no amino acid sequences of AP-I-digested 
peptidic fragments were obtained for the long stretches 
of the N- and C-terminus of the enzyme strongly sug- 
gests that the N- and/or C-terminal regions of the 
translated product might be processed. 
Although the attempt at determining the N-ter- 
minal amino acid sequence of the purified HDC was 
unsuccessful, the ATG codon at nucleotides 1 to 3, 
which is located downstream from the in-frame stop 
codon at nucleotides - 57 to - 55, is concluded to be 
the initiator codon. This assignment is supported by the 
fact that the nucleotide at - 3 position of the ATG 
codon is purine, guanine, as is the rule with eukaryotic 
mRNAs [ll]. 
Fig. 3. Sizing of the mRNA for HDC. Total RNA (10 pg) was 
denatured by treatment with glyoxal and then separated on a 1.0% 
agarose gel. 
amino acids. The calculated M, is 74 017, which is larger 
than that of the purified HDC subunit (53 kDa) [6]. 
One possible explanation for this discrepancy is that 
As shown in Fig. 3, the mRNA encoding the amino 
acid sequence of HDC is 2.7 kb in size. Although we 
cannot rule out the possibility at this time that minor 
HDC mRNA species exist, as was described in rat fetal 
liver [2], we tentatively conclude that the single form of 
HDC mRNA specifies the premature HDC subunit (74 
kDa), which can be posttranslationally processed to 
yield the mature HDC subunit (53 kDa), and that the 
native HDC enzyme is composed of two of the latter 
subunits as previously described [6]. 
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Fig. 4. Homology between the amino acid sequences of HDC of P-815 cells and other decarboxylases. (*) indicates an identical residue. The 
putative PLP-binding domain of HDC is boxed. mHDC, mouse mastocytoma HDC; rHDC, rat liver HDC; rDDC, rat liver DDC; dDDC, 
Drosophila DDC; TDC, periwinkle tryptophan decarboxylase. 
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By screening the protein sequence database of the 
Protein Research Foundation, we found significant 
homology between the sequence of HDC from P-815 
cells and that of fetal rat liver HDC [2]. As shown in 
Fig. 4, the amino acid sequence for P-815 cells shares 
86.1% homology with that for rat liver. HDC from 
P-815 cells also shows significant homology with dopa 
decarboxylases (DDC) from fetal rat liver [12] and 
Drosophila [ 131, and with periwinkle tryptophan decar- 
boxylase (TDC) [14], the homology being 53.3, 48.3 
and 41.6070, respectively. The putative seven-amino acid 
pyridoxal phosphate (PLP)-binding domain (amino 
acids 307-313) and the PLP-binding site (Lys-312) are 
completely identical in both the cDNA and amino acid 
sequences, respectively, in P-815 cells and rat liver. In- 
terestingly, the threonine-307 and serine-311 residues of 
HDC are replaced by asparagine and histidine residues, 
respectively, in rat [12] and Drosophila DDC [13]. 
Although the significance of these differences in this 
domain is unclear, it is possible that the amino acid se- 
quence surrounding the PLP-binding site (lysine) may 
be substrate-specific. 
Four potential N-glycosylation sites [Asn-Xaa-(Thr 
or Ser)] (amino acids 184-186, 223-225, 309-311 and 
559-561) were found in the HDC sequence in P-815 
cells. Of these sites, two (residues 223-225 and 309-3 11) 
are conserved in the rat HDC sequence. Two possible 
sites of phosphorylation by CAMP-dependent protein 
kinase were also observed at amino acids 343-347 and 
362-366. It is likely that these sites are involved in 
CAMP-dependent modulation of HDC activity. In fact, 
dibutyryl cyclic AMP increased HDC activity in 
cultured P-815 cells [5]. 
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